Dr Susan Rossell is a Professor of Cognitive Neuropsychiatry at Swinburne University, Melbourne. She has published over 390 peer-reviewed papers and it's currently running Australia's largest clinical trial examining whether psilocybin assisted psychotherapy is effective for the treatment of treatment resistant depression. The TGA recently moved two psychedelic drugs from Schedule 9, Prohibited Substances to Schedule 8, Controlled Medicines with specific indications for treatment resistant depression and PTSD. Dr Rossell: "I think physiologically, so in terms of our actual physical health, I think we're pretty sad"

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode